Analytical Data
-
基因名
HOM-TES-103
- Application
-
别名
IFFO1; IFFOIntermediate filament family orphan 1; Tumor antigen HOM-TES-103
-
种属
Human
-
表达系统
E. coli
-
标签
His tag C-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q0D2I5
-
表达区间
1-559aa
-
氨基酸序列
MNPLFGPNLF LLQQEQQGLA GPLGDSLGGD HFAGGGDLPP APLSPAGPAA YSPPGPGPAP PAAMALRNDL GSNINVLKTL NLRFRCFLAK VHELERRNRL LEKQLQQALE EGKQGRRGLG RRDQAVQTGF VSPIRPLGLQ LGARPAAVCS PSARVLGSPA RSPAGPLAPS AASLSSSSTS TSTTYSSSAR FMPGTIWSFS HARRLGPGLE PTLVQGPGLS WVHPDGVGVQ IDTITPEIRA LYNVLAKVKR ERDEYKRRWE EEYTVRIQLQ DRVNELQEEA QEADACQEEL ALKVEQLKAE LVVFKGLMSN NLSELDTKIQ EKAMKVDMDI CRRIDITAKL CDVAQQRNCE DMIQMFQVPS MGGRKRERKA AVEEDTSLSE SEGPRQPDGD EEESTALSIN EEMQRMLNQL REYDFEDDCD SLTWEETEET LLLWEDFSGY AMAAAEAQGE QEDSLEKVIK DTESLFKTRE KEYQETIDQI ELELATAKND MNRHLHEYME MCSMKRGLDV QMETCRRLIT QSGDRKSPAF TAVPLSDPPP PPSEAEDSDR DVSSDSSMR
-
分子量
61.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HOM-TES-103 is a recombinant protein that has garnered significant attention in recent years due to its potential applications in therapeutic and diagnostic fields. Developed from a specific gene sequence, HOM-TES-103 exhibits unique biological properties that could be instrumental in various medical research areas, including oncology, immunology, and regenerative medicine. The protein is engineered to enhance stability and functionality, which is crucial for both experimental and clinical purposes. Research surrounding HOM-TES-103 focuses on elucidating its structural characteristics, biological activity, and interaction with other biomolecules, aiming to understand its role in disease mechanisms and treatment responses. Preliminary studies suggest that HOM-TES-103 may play a role in modulating immune responses and promoting tissue regeneration, making it a promising candidate for further exploration. As the scientific community continues to investigate its mechanisms of action and therapeutic potential, HOM-TES-103 stands at the forefront of innovative protein research, offering hope for new strategies in disease management and patient care.
